会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 25. 发明申请
    • POST-EXPOSURE PROPHYLAXIS AND TREATMENT OF INFECTIONS
    • 暴露后预防和治疗感染
    • US20110046039A1
    • 2011-02-24
    • US12530538
    • 2008-03-06
    • Serguei G. PopovTaissia PopovVirginia EspinaCharles BaileyLance A. LiottaEmanuel Petricoin
    • Serguei G. PopovTaissia PopovVirginia EspinaCharles BaileyLance A. LiottaEmanuel Petricoin
    • A61K38/07A61P31/04
    • A61K45/06A61K31/496A61K2300/00
    • The invention provides methods and materials for identifying agents for preventing and/or treating anthrax and similar diseases. Embodiments provide strains and model systems for studying non-lethal and lethal exposure to anthrax and similar disease vectors. Embodiments provide materials and methods for using the strains and model systems for differential profiling, such as proteomic profiling, such as differentiation phosphorylation profiling, to target identification and therapeutics discovery and development. Embodiments provide pharmaceutically acceptable compositions, and methods for using them to prevent and/or treat anthrax and similar diseases comprising an agent that decreases the activity of caspase ¼, such as YVAD, and/or an agent that increases the phosphorylation of AKT, such as IB-MECA or Cl-IB-MECA, together with, in particular embodiments, an antibiotic, such as ciprofloxacin. Kits comprising the same are provided as well, among other things.
    • 本发明提供用于鉴定用于预防和/或治疗炭疽和类似疾病的药剂的方法和材料。 实施例提供用于研究非致死和致死性暴露于炭疽和类似疾病载体的菌株和模型系统。 实施例提供了用于使用菌株和模型系统进行差异分析的材料和方法,例如蛋白质组学分析,例如分化磷酸化分析,以靶向鉴定和治疗发现和发展。 实施方案提供了药学上可接受的组合物,以及使用它们来预防和/或治疗炭疽和类似疾病的方法,其包括降低半胱天冬酶(例如YVAD)的活性的试剂和/或增加AKT磷酸化的试剂,例如 在特定实施方案中,IB-MECA或Cl-IB-MECA,以及抗生素,如环丙沙星。 还提供了包括其的套件,以及其他。